![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 NanoAlvand (2)
02 Accure Labs (1)
03 Alphapharm PTY Ltd (2)
04 Biem Ilac San. ve Tic. A.S (1)
05 CinnaGen Co (1)
06 Clinect (2)
07 EMD Serono (2)
08 Fresenius Kabi Austria (1)
09 Fresenius Kabi USA (1)
10 GENERIC MEDICAL PARTNERS INC (1)
11 Hikma Pharmaceuticals (1)
12 Janssen-Cilag (1)
13 Jodas Expoim Pvt. Ltd (1)
14 Johnson & Johnson Innovative Medicine (2)
15 Key Oncologics (1)
16 Lipomed AG (5)
17 Merck & Co (3)
18 NORVIUM BIOSCIENCE (1)
19 Zhejiang Hisun Pharmaceutical (1)
01 CONCENTRATE FOR SOLUTION FOR INFUSION (1)
02 Cladribine 10Mg 5Ml 5 Units Parenteral Use (1)
03 INJ (2)
04 INJECTABLE;INJECTION (5)
05 INJECTION (1)
06 Injectable (1)
07 Injectable Solution (1)
08 Injection (3)
09 Injection fluid, resolution (1)
10 SOLUTION (2)
11 SOLUTION FOR INJECTION (1)
12 TABLET (1)
13 TABLET;ORAL (1)
14 Vial (2)
15 Blank (7)
01 DISCN (2)
02 Generic (3)
03 Originator (1)
04 Prescription (3)
05 RX (4)
06 Blank (17)
01 CLADRIBINE (4)
02 CLADRIBINE INJECTION (2)
03 LEUSTATIN (1)
04 Leudribine (3)
05 Leustatin (2)
06 Leustatin 10Ml (1)
07 Litak (5)
08 Litak 10 (1)
09 MAVENCLAD (2)
10 Mavenclad (3)
11 Ocladra (1)
12 cladribine (1)
13 Blank (4)
01 Australia (7)
02 Canada (3)
03 India (2)
04 Iran (3)
05 Italy (1)
06 Norway (1)
07 South Africa (2)
08 Sweden (2)
09 Switzerland (2)
10 Turkey (1)
11 USA (6)